Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 2Glioblastoma 2Ependymoma 2Brain Neoplasms 2Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Diffuse Intrinsic Pontine Glioma 1Adenocarcinoma 1

Interventions

Cyclophosphamide 15Temozolomide 11Vincristine 10Magnetic Resonance Spectroscopy 10Cisplatin 10Specimen Handling 8Radiotherapy 8Etoposide 8X-Rays 6Phantoms, Imaging 6Carboplatin 6Nuclear Medicine Department, Hospital 5Lomustine 5Radiation 4Platinum 4Methotrexate 4Irinotecan 4Filgrastim 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4etoposide phosphate 3Thiotepa 3Nivolumab 3Granulocyte Colony-Stimulating Factor 3Celecoxib 3Bevacizumab 3Automobiles 3ulixertinib 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Medulloblastoma × 1-methyltryptophan × 1 year × Clear all
NCT05106296 2026-01-09

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Augusta University

Phase 1 Recruiting
37 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT04049669 2026-01-08

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Augusta University

Phase 2 Active not recruiting
130 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡